As CD44 positively regulates the proliferation of breast cancer cells [31,41], we investigated whether combining the two drugs in concentrations affecting CD44 levels would have an impact on MDA-MB-231 cell propagation. This evidence concerns the gene CD44 and breast carcinoma.